122 related articles for article (PubMed ID: 22914809)
1. Mean platelet volume and related factors in patients at different stages of diabetic nephropathy: a preliminary study.
Turgutalp K; Özhan O; Akbay E; Tombak A; Tiftik N; Ozcan T; Yilmaz S; Helvaci I; Kiykim A
Clin Appl Thromb Hemost; 2014 Mar; 20(2):190-5. PubMed ID: 22914809
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for progression of renal disease in patient with diabetic nephropathy.
Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria in type 2 diabetic patients with renal impairment: the changing face of diabetic nephropathy.
Packham DK; Ivory SE; Reutens AT; Wolfe R; Rohde R; Lambers Heerspink H; Dwyer JP; Atkins RC; Lewis J;
Nephron Clin Pract; 2011; 118(4):c331-8. PubMed ID: 21293156
[TBL] [Abstract][Full Text] [Related]
5. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
[TBL] [Abstract][Full Text] [Related]
6. [Variance of mean platelet volume in subjects with normal glucose tolerance, impaired glucose regulation and type 2 diabetic mellitus and its relationship with diabetic peripheral artery disease].
Li S; Wang C; Zhong XW; Li HQ; Fu XQ; Ran XW
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):232-5. PubMed ID: 22490792
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
9. Excess renal insufficiency among type 2 diabetic patients with dip-stick positive proteinuria in a tertiary hospital.
Balogun WO; Abbiyesuku FM
Afr J Med Med Sci; 2011 Dec; 40(4):399-403. PubMed ID: 22783692
[TBL] [Abstract][Full Text] [Related]
10. Could mean platelet volume be a promising biomarker of progression of chronic kidney disease?
Ju HY; Kim JK; Hur SM; Woo SA; Park KA; Park MY; Choi SJ; Hwang SD
Platelets; 2015; 26(2):143-7. PubMed ID: 24679226
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
12. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
[TBL] [Abstract][Full Text] [Related]
13. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
14. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
17. Mean platelet volume in patients with type 2 diabetes mellitus.
Papanas N; Symeonidis G; Maltezos E; Mavridis G; Karavageli E; Vosnakidis T; Lakasas G
Platelets; 2004 Dec; 15(8):475-8. PubMed ID: 15763888
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the relationship between serum apelin levels and vitamin D and mean platelet volume in diabetic patients.
Kiskac M; Zorlu M; Cakirca M; Karatoprak C; Kesgin S; Büyükaydın B; Yavuz E; Ardic C; Camli AA; Cikrikcioglu MA
Ann Endocrinol (Paris); 2014 Sep; 75(4):200-5. PubMed ID: 25156130
[TBL] [Abstract][Full Text] [Related]
19. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis.
Liu J; Liu X; Li Y; Quan J; Wei S; An S; Yang R; Liu J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29581246
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
Guo LL; Pan Y; Jin HM
Nephrol Dial Transplant; 2009 Jun; 24(6):1876-83. PubMed ID: 19164322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
